Mifegyne vs Mifepristone Linepharma: Side-by-Side Comparison
Quick answer: Mifegyne and Mifepristone Linepharma are both antiprogestogen (selective progesterone receptor modulator) used for similar indications. They share a mechanism of action but differ in dosing, half-life, side-effect profile, and clinical preferences. Switching between them is a clinical decision.
Side-by-side comparison
| Feature | Mifegyne | Mifepristone Linepharma |
|---|---|---|
| Drug class | Antiprogestogen (selective progesterone receptor modulator) | Antiprogestogen (selective progesterone receptor modulator) |
| ATC code | G03XB01 | G03XB01 |
| Primary indications | Medical termination of pregnancy, Cervical ripening | Medical termination of pregnancy |
| Mechanism | Brand name for mifepristone, a competitive progesterone receptor antagonist that terminates pregnancy by blocking progesterone action on the endometrium | Linepharma-branded mifepristone, a competitive progesterone receptor antagonist used for medical abortion in combination with a prostaglandin |
| Common dose | 200 mg orally, followed by misoprostol | 200 mg single oral dose followed by misoprostol |
| Detail page | Mifegyne details → | Mifepristone Linepharma details → |
How to choose between Mifegyne and Mifepristone Linepharma
Both medicines belong to the same therapeutic class and address overlapping indications. Selection between them depends on:
- Patient-specific factors: age, kidney and liver function, other medications, allergies, comorbidities
- Specific clinical indication: some class members are preferred for particular conditions or guideline recommendations
- Dosing preference: once-daily vs twice-daily, oral vs injectable, food requirements
- Tolerability: individual side-effect profiles vary even within a class
- Drug interactions: patient's other medications may interact differently with each option
- Cost and availability: generic availability, insurance coverage, regional access
Should you switch?
Switching between class members is a clinical decision, not a self-help one. Reasons your prescriber may consider switching include:
- Inadequate response to current medication
- Side effects affecting quality of life
- New drug interactions due to a recently added medication
- Cost or availability changes
- Updated guidelines favoring a different option
Never switch medications, change dose, or stop without consulting your prescriber.
Related
All Antiprogestogen (selective progesterone receptor modulator) on iMedic · Mifegyne full details · Mifepristone Linepharma full details
Frequently asked questions
Is Mifegyne better than Mifepristone Linepharma?
Neither is universally 'better.' They are both antiprogestogen (selective progesterone receptor modulator) with similar mechanisms of action. The right choice depends on the specific clinical situation, patient factors, dosing preferences, drug interactions, and tolerability. Discuss with your prescriber.
Can I switch from Mifegyne to Mifepristone Linepharma?
Switching is possible but should be done under clinical supervision. Different class members may not be interchangeable on a 1:1 dose basis, and tapering or transition strategies vary. Never switch on your own.
Do Mifegyne and Mifepristone Linepharma have the same side effects?
They share class-wide side-effect tendencies but differ in individual profiles. Some patients tolerate one better than the other. Specific frequency and severity of side effects can be found on each medicine's individual page.
Are Mifegyne and Mifepristone Linepharma available as generics?
Generic availability depends on patent status in your country. Most well-established class members are available generically and are clinically equivalent to brand-name versions.
Last reviewed: by iMedic Medical Editorial Team. Our editorial process.